E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/29/2006 in the Prospect News Biotech Daily.

HemaCare amends facility to augment available funds, prolong maturity

By Jennifer Chiou

New York, Sept. 29 - HemaCare Corp. entered into an amended and restated loan and security agreement to increase to $3 million from $2 million the amount available under its credit facility and to extend the maturity date to June 30, 2008, according to an 8-K filing with the Securities and Exchange Commission.

The Woodland Hills, Calif., blood products provider reached agreements with Coral Blood Services, Inc. HemaCare BioScience, Inc. and Comerica Bank.

The amendment also grants Comerica a first-priority security interest in HemaCare, the filing said.

The company said it has $1 million available under the credit facility.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.